BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

3D Biomatrix Awarded a Phase I STTR Award to Develop 3D Metastatic Prostate Cancer Assay


4/26/2012 11:15:56 AM

April 26, 2012 -- 3D Biomatrix, which develops and sells tools that mimic the human cellular environment for drug discovery research and testing, has been awarded a Phase I STTR grant from the National Institutes of Health (NIH) for further development of its Perfecta3DTM Hanging Drop Plates to develop a three-dimensional (3D) cell assay for metastatic prostate cancer.

3D Biomatrix, a life sciences company developing and marketing revolutionary solutions for three dimensional (3D) cell cultures, was recently awarded a Phase I STTR grant from the National Institutes of Health (NIH) for the development of a high throughput drug screening metastatic prostate cancer assay utilizing 3D Biomatrix’s Perfecta3D Hanging Drop Plates. The effort for this grant will be shared by 3D Biomatrix and the laboratory of Professor Shuichi Takayama at the University of Michigan.

Despite the high prevalence of prostate cancer among men in the United States, there is a lack of effective therapies against metastatic versions of the disease. The work described in the STTR grant will facilitate the development of better drugs by providing a high throughput assay that mimics prostate cancer metastasized to bone.

“Three-dimensional cell cultures provide in vitro models that mimic tissues that cannot be modeled in two-dimensions, such as prostate cancer metastasized to bone. The work described in this grant will make this 3D model available in a format ideal for drug discovery.” said 3D Biomatrix CEO Laura Schrader. “The impact for potential treatments is huge.”

Perfecta3D Hanging Drop Plates have been used to mimic prostate, breast, colon, kidney, and other cancers. The Plates are currently available from 3D Biomatrix.

About the Company

3D Biomatrix, LLC is a life sciences company developing and marketing revolutionary solutions for three dimensional (3D) cell cultures. Cells grown on 3D Biomatrix products have been shown to retain a much higher complexity of body response than cells grown in traditional two-dimensional plates and flasks.

www.3dbiomatrix.com


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->